Implanet SA (IM11) AI Stock Analysis

Implanet SA

(Frankfurt:IM11)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Revenue reboundThe strong revenue rebound indicates improving commercial traction for Implanet’s orthopedic and spinal product portfolio. If maintained, expanding sales can support greater operating leverage, broader surgeon and hospital adoption, and a larger base from which the company can pursue eventual profitability.

Negative Factors

Persistent unprofitabilityPersistent operating and net losses show that the recent revenue and margin recovery has not yet translated into a sustainable earnings model. Continued losses can consume financial resources, restrict investment capacity, and delay the point at which growth becomes self-funded rather than dependent on outside capital.

Implanet SA (IM11) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 19.67M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -5.0
Beta (1Y): -0.32
Revenue Growth: 24.35%
EPS Growth: 15.00%
Country: Germany
Employees: 49
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Devices

Implanet SA Business Overview & Revenue Model

Company Description

Implanet S.A., together with its associated companies, is dedicated to the research, development, manufacturing, and commercialization of spinal and orthopedic medical implants. The firm's product portfolio addresses both spinal and knee needs. Its s...

Implanet SA Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:IM11 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FR:CVX	55Neutral	EUR 313.62M	-7.60	-120.57%	―	-100.00%	-72.33%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
FR:ALTHE	46Neutral	EUR 48.69M	-6.13	453.10%	―	-16.98%	20.31%
FR:ALMDT	43Neutral	EUR 194.08M	-3.46	271.64%	―	2.16%	-5.26%
FR:ALMKT	40Underperform	EUR 18.53M	1.46	-157.72%	―	3.38%	―

* Healthcare Sector Average

Performance Comparison

DE:IM11 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:IM11	Implanet SA	0.13	-0.08	-37.56%
FR:ALMKT	MAUNA KEA TECHNOLOGIES	0.09	0.01	5.75%
FR:ALTHE	Theraclion SA	0.63	-0.04	-6.49%
FR:ALDMS	Diagnostic Medical Systems	0.90	-0.40	-30.77%
FR:ALMDT	Median Technologies	4.25	1.17	38.15%
FR:CVX	Affluent Medical SA	4.94	3.36	212.66%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Implanet SA AI Stock Analysis